EUVIMEDOntdek EUVIMED
Crossref

Ginsenoside Re inhibits non‐small cell lung cancer progression by suppressing macrophage M2 polarization induced by AMPKα1 / STING positive feedback loop

Xiaoyu Tang, Man Zhu, Zeren Zhu, Wenjun Tang, Hongmei Zhang, Yanbin Chen, Feng Liu, Yanmin Zhang iD

Phytotherapy Research · 2024-11 · 38 (11) · 5088-5106

DOI: 10.1002/ptr.8309 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2024-08-09. Written by Xiaoyu Tang and 7 co-authors. Institution: School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China. Major MEDLINE topics: Ginsenosides, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, AMP-Activated Protein Kinases. Cited 18 times so far (Crossref); 43 references. Funded by: Yangzheng Mixture Efficacy Research Project by Shaanxi Buchang Pharmaceutical, Central Universities Basic Research Funds, National Natural Science Foundation of China.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Tumor‐associated macrophages (TAMs) in non‐small cell lung cancer (NSCLC) promote tumor cell metastasis by interacting with cancer cells. Ginsenoside Re is capable of modulating the host immune system and exerts anticancer effects through multiple pathways. Both AMPK and STING are involved in the regulation of MΦ polarization, thereby affecting tumor progression. However, whether there is a regulatory relationship between them and its effect on MΦ polarization and tumor progression is unclear. The aim of this study was to provide mechanistic evidence that ginsenoside Re modulates MΦ phenotype through inhibition of the AMPKα1/STING positive feedback loop and thus exerts an antimetastatic effect in NSCLC immunotherapy. Cell culture models and conditioned media (CM) systems were constructed, and the treated MΦ were analyzed by database analysis, RT‐PCR, Western blotting, flow cytometry, and immunofluorescence to determine the regulatory relationship between AMPK and STING and the effects of ginsenoside Re on MΦ polarization and tumor cells migration. The effects of ginsenoside Re (10, 20 mg/kg/day) on TAMs phenotype as well as tumor progression in mice were assessed by HE staining, immunohistochemical staining, and Western blotting. In this study, AMPKα1/STING positive feedback loop in NSCLC TAMs induced M2 type polarization, which in turn promoted NSCLC cell migration. In addition, ginsenoside Re was discovered to inhibit M2‐like MΦ polarization, thereby inhibiting NSCLC cell migration. Mechanistically, Re was able to inhibit the formation of the AMPKα1/STING positive feedback loop, thereby inhibiting its induction of M2‐like MΦ and consequently inhibiting the epithelial‐mesenchymal transition (EMT) process of NSCLC cells. Furthermore, in mouse models, Re was found to suppress LLC tumor growth and colonization by inhibiting M2‐type polarization of TAMs. Our finding indicates that ginsenoside Re can effectively modulate MΦ polarization and thus play an important role in antimetastatic immunotherapy of NSCLC.

Subjects

MeSH terms (MEDLINE)

GinsenosidesCarcinoma, Non-Small-Cell LungLung NeoplasmsAMP-Activated Protein KinasesAnimalsMiceHumansCell Line, TumorCell MovementMembrane ProteinsMacrophagesTumor-Associated MacrophagesDisease ProgressionCell Polarity

Author keywords

AMPKα1NSCLCSTINGginsenoside Remacrophage polarization

Substances

GinsenosidesAMP-Activated Protein Kinasesginsenoside ReMembrane Proteins

Authors and institutions

  • School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China.
  • State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, Xi'an Jiaotong University, Xi'an, China.
  • Department of Endocrinology, Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
  • Shaanxi Buchang Pharmaceutical Co. Ltd, Xi'an, China.

ORCID profiles: Yanmin Zhang

Funding

  • Yangzheng Mixture Efficacy Research Project by Shaanxi Buchang Pharmaceutical
  • Central Universities Basic Research Funds
  • National Natural Science Foundation of China
  • Shaanxi Province Science and Technology Development Plan Project
  • Shaanxi Province Science Fund for Distinguished Young Scholars
  • Central Guided Local Science and Technology Development Fund Project

Cite

APA

Tang, X., Zhu, M., Zhu, Z., Tang, W., Zhang, H., Chen, Y., Liu, F., & Zhang, Y. (2024). Ginsenoside Re inhibits non‐small cell lung cancer progression by suppressing macrophage M2 polarization induced by AMPKα1 / STING positive feedback loop. Phytotherapy Research, 38(11), 5088-5106. https://doi.org/10.1002/ptr.8309

Vancouver

Tang X, Zhu M, Zhu Z, Tang W, Zhang H, Chen Y, et al. Ginsenoside Re inhibits non‐small cell lung cancer progression by suppressing macrophage M2 polarization induced by AMPKα1 / STING positive feedback loop. Phytotherapy Research. 2024;38(11):5088-5106. doi:10.1002/ptr.8309

BibTeX
@article{Tang2024,
  author = {Tang, Xiaoyu and Zhu, Man and Zhu, Zeren and Tang, Wenjun and Zhang, Hongmei and Chen, Yanbin and Liu, Feng and Zhang, Yanmin},
  title = {Ginsenoside Re inhibits non‐small cell lung cancer progression by suppressing macrophage M2 polarization induced by AMPKα1 / STING positive feedback loop},
  journal = {Phytotherapy Research},
  year = {2024},
  volume = {38},
  number = {11},
  pages = {5088--5106},
  doi = {10.1002/ptr.8309}
}
Start for free →